🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT03062085
Recruiting Observational

Shanghai High Myopia Study

NCT03062085 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai High Myopia Study Group
Phase
Observational
Started
2015-01-01
Last updated
2026-05-11

Condition(s) studied

High MyopiaCataractVisual OutcomeGenetic Anticipation

Investigational drug(s) / intervention(s)

Cataract

Cataract: The genetic and environmental factors concerning to the pathogenesis of cataract in the three groups.

Study summary

The purpose of this study is to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of high myopic cataract and age-related cataract patients. The investigators will further investigate into the various genetic and environmental factors that may contribute to the pathogenesis of high myopic cataract.

Eligibility

Sex
ALL
Min age
20 Years
Max age
100 Years
Healthy volunteers
No
Inclusion Criteria: * Clinical diagnosis of cataract * Must be able to cooperate with the ophthalmic examination Exclusion Criteria: * Clinical diagnosis of mental illness * Mentally disabled

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Eye and ENT Hospital of Fudan University Shanghai Shanghai Municipality Recruiting

More Shanghai High Myopia Study Group trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03062085 on ClinicalTrials.gov ↗ ← All trials in China